NO942360L - Vaksine og polypeptider som er nyttige for denne - Google Patents

Vaksine og polypeptider som er nyttige for denne

Info

Publication number
NO942360L
NO942360L NO942360A NO942360A NO942360L NO 942360 L NO942360 L NO 942360L NO 942360 A NO942360 A NO 942360A NO 942360 A NO942360 A NO 942360A NO 942360 L NO942360 L NO 942360L
Authority
NO
Norway
Prior art keywords
xaa
vaccine
xaa2
gly
polypeptides useful
Prior art date
Application number
NO942360A
Other languages
English (en)
Other versions
NO942360D0 (no
Inventor
Andrew Richard Milner
Michael Panaccio
Terence William Spithill
Gene Louise Wijffels
Original Assignee
Daratech Proprietary Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daratech Proprietary Ltd filed Critical Daratech Proprietary Ltd
Publication of NO942360D0 publication Critical patent/NO942360D0/no
Publication of NO942360L publication Critical patent/NO942360L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Peptider oppnåelige fra en art av Fasciola omfattende den følgende sekvens: Gln-Xaa-Xaa-Xaa-Xaa1-Xaa-Cys-Trp-Xaa-Xaa-Xaa2 hvori Xaa er en hvilken som helst aminosyre, Xaaj er Gly eller Glu og Xaa2 er Ser, Thr, Ala eller Gly er omtalt. Der omtales også vaksiner og fremgangsmåter for behandling for å redusere spredningen av infeksjon av leverikte og DNA-sekvenser av polypeptidene.
NO942360A 1993-02-05 1994-06-21 Vaksine og polypeptider som er nyttige for denne NO942360L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPL710993 1993-02-05
PCT/AU1994/000051 WO1994017820A1 (en) 1993-02-05 1994-02-04 Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same

Publications (2)

Publication Number Publication Date
NO942360D0 NO942360D0 (no) 1994-06-21
NO942360L true NO942360L (no) 1994-10-05

Family

ID=3776688

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942360A NO942360L (no) 1993-02-05 1994-06-21 Vaksine og polypeptider som er nyttige for denne

Country Status (8)

Country Link
EP (1) EP0647138A4 (no)
JP (1) JPH07505787A (no)
AU (1) AU5996294A (no)
BR (1) BR9404004A (no)
CA (1) CA2126455A1 (no)
NO (1) NO942360L (no)
NZ (1) NZ261279A (no)
WO (1) WO1994017820A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9407614A (pt) * 1993-09-28 1997-01-14 Univ Melbourne Antígenos protetores putatívos ou seus fragmentos contra ostertagia circumcincta trichostrongylus colubriformis e fasciola hepatica processo para preparar um antígeno associado a um patógeno de doença selecionado de espécies fasciola ostertagia e trichostrongylus processo para preparar um anticorpo monoclonal anticorpo monoclonal processo para preparar polipeptídeo antigênico sintético kit para diagnóstico processo para prevenir doenças em animais processo para o tratamento de doenças em animais
DE69840433D1 (de) * 1997-03-11 2009-02-26 Stichting Dienst Landbouwkundi Fasciola hepatica impfstoffe
WO2002038744A2 (en) * 2000-10-18 2002-05-16 Incyte Genomics, Inc. Proteases
IL262513B (en) * 2002-09-11 2022-09-01 Genentech Inc Cleaning proteins
PL201419B1 (pl) * 2002-12-04 2009-04-30 Inst Biotechnologii I Antybiot Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina
PL196114B1 (pl) * 2002-12-31 2007-12-31 Inst Biotechnologii I Antybiot Ciałka inkluzyjne jako antygeny do doustnej immunizacji zwierząt
BR112012008185A2 (pt) * 2009-10-07 2016-08-16 Wyeth Llc composições que compreendem adjuvante, macrolídeo e antígeno proteináceo, e métodos para uso dessas composições
ES2525106B1 (es) * 2013-06-17 2015-09-29 Universidad De Salamanca Péptido sintético derivado de Fasciola hepatica y su uso como vacuna
GB201714057D0 (en) * 2017-09-01 2017-10-18 Univ College Dublin Nat Univ Of Ireland Dublin A fasciola hepatica antigen and vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8432401D0 (en) * 1984-12-21 1985-02-06 Bennett C E Liver fluke antigens
AU7871987A (en) * 1986-08-18 1988-03-08 Australian National University, The Helminth parasite vaccine
JPH04507235A (ja) * 1989-01-31 1992-12-17 ダラテック　ピーテーワイ　リミテッド 反芻動物における肝吸虫感染に対する予防治療のためのワクチン
JP2700088B2 (ja) * 1991-07-25 1998-01-19 房則 濱島 免疫抑制剤
ES2199947T3 (es) * 1992-10-21 2004-03-01 John Pius Dalton Vacuna que contiene una tiolproteasa.

Also Published As

Publication number Publication date
BR9404004A (pt) 1999-05-25
JPH07505787A (ja) 1995-06-29
CA2126455A1 (en) 1994-08-06
EP0647138A4 (en) 1996-03-06
NO942360D0 (no) 1994-06-21
NZ261279A (en) 1996-03-26
EP0647138A1 (en) 1995-04-12
AU5996294A (en) 1994-08-29
WO1994017820A1 (en) 1994-08-18

Similar Documents

Publication Publication Date Title
NL300013I1 (nl) Nieuwe protein met TNF-remmende werking en hun ber
CA2489227A1 (en) Hla-a24-restricted cancer antigen peptides
EP2019118B1 (en) Method for synthesizing thymosins
MX9703643A (es) Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana.
HUP0302965A2 (hu) Vakcina
IE63547B1 (en) Anticoagulant peptides
DE69435075D1 (de) , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
TR199802534T2 (xx) Leptin (OB Protein) fragmanlar�
ATE314083T1 (de) Lysin enthaltende peptide zur behandlung von herzkrankheiten
NO942360L (no) Vaksine og polypeptider som er nyttige for denne
NO941151L (no) Lineære adhesjonsinhibitorer
HUP0100267A2 (hu) Helicobacter pylori eredetű nukleinsav- és aminosav-szekvenciák és a megfelelő nukleinsavakat vagy peptideket tartalmazó vakcina-készítmények
JP2916164B2 (ja) 抗凝固剤ペプチドアルコール類
ATE177843T1 (de) Peptomere mit erhöhter immunogenizität
AU630132B2 (en) Anticoagulant peptides
US5541161A (en) Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
ATE201693T1 (de) Hämoregulierende peptide
NO975565L (no) Benstimulerende faktor
ES2176334T3 (es) El uso de gabapentin en el tratamiento de la ansiedad y el panico.
DE3782880D1 (de) Hemmende peptide.
ES2032812T3 (es) Vacuna.
RU95120588A (ru) Циклогексапептиды, их смеси, способ их получения и применения
US5789540A (en) Anticoagulant peptides
DK0811067T3 (da) Equin arteritisviruspeptider, antistoffer og deres anvendelse i en diagnostisk test